Metoclopramide Injection, USP (5 mg/mL) is used to treat and prevent nausea, vomiting, and delayed gastric emptying. It’s especially effective for patients with diabetic gastroparesis, chemotherapy-induced nausea, and post-operative recovery. Administered via IV or IM, this dopamine antagonist enhances gastrointestinal motility and supports smoother diagnostic procedures like small bowel intubation and radiological exams.

Key Benefits:
- Rapid onset for acute nausea and vomiting
- Proven efficacy in diabetic gastroparesis
- Supports GI procedures requiring enhanced motility
- Available in sterile 2 mL vials (10 mg total dose)
- Suitable for IV or IM administration

Important Safety Note:
Use is limited to short-term therapy due to the risk of tardive dyskinesia, a serious movement disorder. Not recommended for use beyond 12 weeks.